Other News To Note

• Cardiome Pharma Corp., of Vancouver, British Columbia, reached an agreement with Merck & Co. Inc., of Whitehouse Station, N.J., to settle its debt obligations stemming from the companies' collaboration and license agreement for heart drug vernakalant, signed in April 2009 and subsequently terminated.